Cotrimoxazole plasma levels, dialyzer clearance and total removal by extended dialysis in a patient with acute kidney injury: Risk of under-dosing using current dosing recommendations

BMC Pharmacology and Toxicology

Volumn 14, Issue , 2013, Pages

  Clajus, Christian ^a   Kühn Velten, W Nikolaus ^b   Schmidt, Julius J ^a   Lorenzen, Johan M ^a   Pietsch, Daniel ^a   Beutel, Gernot ^a   Kielstein, Jan T ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Medizinisches Labor Bremen   (Germany)

Author keywords

Antibiotics; Drug monitoring; Intensive care unit; Pharmacokinetics

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; PREDNISOLONE; SULFAMETHOXAZOLE; TRIMETHOPRIM; ANTIINFECTIVE AGENT; COTRIMOXAZOLE;

ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC THERAPY; AORTA VALVE REGURGITATION; ARTICLE; ARTIFICIAL KIDNEY; ARTIFICIAL VENTILATION; BLADDER CARCINOMA; BOLUS INJECTION; BRONCHOSCOPY; CAROTID ATHEROSCLEROSIS; CASE REPORT; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG UNDERDOSE; HEART INFARCTION; HEMODIALYSIS; HEMOPTYSIS; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTERSTITIAL PNEUMONIA; LEG THROMBOSIS; MALE; MAXIMUM PLASMA CONCENTRATION; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PULMONARY VASCULITIS; RELAPSE; REPEAT PROCEDURE; SECONDARY HYPERPARATHYROIDISM; TACHYPNEA; THORAX RADIOGRAPHY; TREATMENT DURATION; BLOOD; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; AGED; ANTI-INFECTIVE AGENTS; HUMANS; MALE; RENAL DIALYSIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

MLCS; MLOWN;

EID: 84879812247     PISSN: 20506511     EISSN: None     Source Type: Journal    
DOI: 10.1186/2050-6511-14-19     Document Type: Article

References (15)

1. Cohen SD, Chawla LS, Kimmel PL. Acute kidney injury in patients with human immunodeficiency virus infection. Curr Opin Crit Care 2008, 14(6):647-653. 10.1097/MCC.0b013e3283186f43, 19005305.
2. Heintz BH, Matzke GR, Dager WE. Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis. Pharmacotherapy 2009, 29(5):562-577. 10.1592/phco.29.5.562, 19397464.
3. Curkovic I. Trimethoprim/Sulfamethoxazole pharmacokinetics in two patients undergoing continuous venovenous hemodiafiltration. Ann Pharmacother 2010, 44(10):1669-1672. 10.1345/aph.1P160, 20823279.
4. Fliser D, Kielstein JT. Technology Insight: treatment of renal failure in the intensive care unit with extended dialysis. Nat Clin Pract Nephrol 2006, 2(1):32-39.
5. Kielstein JT, Schiffer M, Hafer C. Back to the future: extended dialysis for treatment of acute kidney injury in the intensive care unit. J Nephrol 2010, 23(5):494-501.
6. Czock D. Pharmacokinetics of moxifloxacin and levofloxacin in intensive care unit patients who have acute renal failure and undergo extended daily dialysis. Clin J Am Soc Nephrol 2006, 1(6):1263-1268. 10.2215/CJN.01840506, 17699357.
7. Kielstein JT. Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis-a pharmacokinetic study. Nephrol Dial Transplant 2010, 25(5):1537-1541. 10.1093/ndt/gfp704, 20031929.
8. Lorenzen JM. Pharmacokinetics of ampicillin/sulbactam in critically ill patients with acute kidney injury undergoing extended dialysis. Clin J Am Soc Nephrol 2012, 7(3):385-390. 10.2215/CJN.05690611, 3302675, 22223613.
9. Matzke GR. Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from kidney disease: improving global outcomes (KDIGO). Kidney Int 2011, 80(11):1122-1137. 10.1038/ki.2011.322, 21918498.
10. Fliser D, Kielstein JT. A single-pass batch dialysis system: an ideal dialysis method for the patient in intensive care with acute renal failure. Curr Opin Crit Care 2004, 10(6):483-488.
11. Gahl G. Kinetic studies on a chemotherapeutic drug combination (sulfamethoxazole and trimethoprim) in chronic kidney insufficiency. Verh Dtsch Ges Inn Med 1971, 77:1017-1019.
12. Craig WA, Kunin CM. Trimethoprim-sulfamethoxazole: pharmacodynamic effects of urinary pH and impaired renal function. Studies in humans. Annals of internal medicine 1973, 78(4):491-497.
13. Nissenson AR, Wilson C, Holazo A. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis. Am J Nephrol 1987, 7(4):270-274. 10.1159/000167484, 3500644.
14. Paap CM, Nahata MC. Clinical use of trimethoprim/sulfamethoxazole during renal dysfunction. DICP: the annals of pharmacotherapy 1989, 23(9):646-654.
15. Wharton JM. Trimethoprim-sulfamethoxazole or pentamidine for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A prospective randomized trial. Ann Intern Med 1986, 105(1):37-44.